Ospedale S. Giovanni Bellinzona   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Bellinzona Switzerland (1300)

Organization Overview

First Clinical Trial
2003
NCT00066703
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bellinzona Hospital, Switzerland | Davide La Regina | Department of Anaesthesiology, Ospedale Regionale di Bellinzona e Valli-Bellinzona, CH-6500 Bellinzona, Switzerland | Institute of Oncology Research (IOR) | Institute of Southern Switzerland IOSI, Bellinzona | IOSI | IOSI, Bellinzona, Switzerland | IOSI Oncology Institute of Southern Switzerland | IOSI, Ospedale San Giovanni, Bellinzona | IOSI Sponsor Unit | Istituto Oncologico della Svizzera Italiana -6500 Bellinzona, Switzerland | Oncology Institute of Southern Switzerland | Oncology Institute of Southern Switzerland - Bellinzona, CH | Oncology Institute of Southern Switzerland, Bellinzona Hospital, 6500 Bellinzona, Switzerland | Oncology Institute of Southern Switzerland - Bellinzona, Switzerland | Oncology Institute of Southern Switzerland IOSI, Bellinzona | Oncology Institute of Southern Switzerland - Ospedale S. Giovanni Bellinzona CH | Ospedale Regionale Bellinzona e Valli | Ospedale Regionale di bellinzona e Valli

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Embolism (Phase 3)

Endometrial Neoplasms (Phase 1)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 1)

Ovarian Neoplasms (Phase 1)

Pain, Postoperative (Phase 4)

Pulmonary Embolism (Phase 3)

Small Cell Lung Carcinoma (Phase 1)

Stomach Neoplasms (Phase 2)

Thrombosis (Phase 3)

Venous Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 26
  • # of Trial APIs: 39